Byers Capital
Byers Capital focuses on investing in startups in Series A + B rounds.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Byers Capital Information
Geographic Data
Address: -
City: San Francisco
State: CA
Zip: 94016
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Byers Capital focuses on investing in startups in Series A + B rounds.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2022 | Culdesac | Series A | 0 |
| 2/2022 | Synapticure | Seed Round | 0 |
| 2/2022 | Getlabs | Series A | 0 |
| 4/2022 | Ostro | Series B | 0 |
| 12/2022 | Ostro | Venture Round | 0 |
| 12/2019 | RxDefine | Series A | - |
| 12/2021 | Freenome | Series D | 300M |
| 11/2022 | Vial | Series B | 67M |
| 4/2021 | Benchling | Series E | 0 |
| 9/2022 | ArsenalBio | Series B | 0 |
| 4/2022 | Waltz Health | Series A | 0 |
| 12/2022 | Ostro | Venture Round | 0 |
| 11/2022 | Vial | Series B | 0 |
| 9/2022 | ArsenalBio | Series B | 0 |
| 4/2022 | Waltz Health | Series A | 0 |
| 4/2022 | Ostro | Series B | 0 |
| 2/2022 | Getlabs | Series A | 0 |
| 2/2022 | Synapticure | Seed Round | 0 |
| 1/2022 | Culdesac | Series A | 0 |
| 12/2021 | Freenome | Series D | 0 |
| 4/2021 | Benchling | Series E | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
